Aquarius Surgical Technologies Inc. (CSE:ASTI)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Aug 21, 2026, 2:10 PM EST
CSE:ASTI Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.04 | 0.01 | 0.11 | 0.12 | 0.16 |
Cash & Short-Term Investments | 0.04 | 0.01 | 0.11 | 0.12 | 0.16 |
Cash Growth | 488.85% | -92.96% | -11.99% | -22.87% | 8.37% |
Accounts Receivable | 0.04 | 0.03 | 0.03 | 0.06 | 0.09 |
Other Receivables | 0.01 | 0.01 | 0.01 | 0.02 | - |
Receivables | 0.05 | 0.05 | 0.05 | 0.08 | 0.35 |
Inventory | - | 0.02 | 0.02 | 0.04 | 0.04 |
Prepaid Expenses | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 |
Total Current Assets | 0.11 | 0.1 | 0.19 | 0.27 | 0.61 |
Property, Plant & Equipment | - | 0.05 | 0.08 | 0.1 | 0.01 |
Long-Term Investments | 1.8 | 1.8 | 0.3 | 0.3 | 0.28 |
Total Assets | 1.91 | 1.95 | 0.57 | 0.68 | 0.89 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.1 | 0.08 | 0.12 | 0.16 | 0.87 |
Accrued Expenses | 0.07 | 0.07 | 0.07 | 0.07 | - |
Short-Term Debt | 0.42 | 0.46 | 0.33 | 0.19 | 0.16 |
Current Portion of Long-Term Debt | 0.15 | - | 0.38 | 0.28 | 0.62 |
Current Portion of Leases | - | 0.03 | 0.02 | 0.03 | - |
Other Current Liabilities | 1.22 | 1.11 | 0.96 | 0.79 | - |
Total Current Liabilities | 1.97 | 1.74 | 1.87 | 1.51 | 1.65 |
Long-Term Debt | 6.37 | 5.96 | 3.25 | 2.93 | 2.46 |
Long-Term Leases | - | 0.03 | 0.05 | 0.08 | - |
Total Liabilities | 8.34 | 7.72 | 5.18 | 4.53 | 4.11 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 19.95 | 19.95 | 19.95 | 19.95 | 19.87 |
Additional Paid-In Capital | 9.32 | 9.32 | 9.32 | 9.32 | 9.3 |
Retained Earnings | -35.69 | -35.04 | -33.87 | -33.12 | -32.39 |
Shareholders' Equity | -6.42 | -5.77 | -4.61 | -3.85 | -3.21 |
Total Liabilities & Equity | 1.91 | 1.95 | 0.57 | 0.68 | 0.89 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 6.94 | 6.47 | 4.04 | 3.51 | 3.24 |
Net Cash (Debt) | -6.9 | -6.46 | -3.93 | -3.39 | -3.08 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.25 | -0.23 | -0.14 | -0.14 | -0.13 |
Filing Date Shares Outstanding | 27.6 | 27.6 | 27.6 | 27.6 | 23.68 |
Total Common Shares Outstanding | 27.6 | 27.6 | 27.6 | 27.6 | 23.68 |
Working Capital | -1.85 | -1.64 | -1.68 | -1.24 | -1.04 |
Book Value Per Share | -0.23 | -0.21 | -0.17 | -0.14 | -0.14 |
Tangible Book Value | -6.42 | -5.77 | -4.61 | -3.85 | -3.21 |
Tangible Book Value Per Share | -0.23 | -0.21 | -0.17 | -0.14 | -0.14 |
Machinery | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |